MedTrace Logo

Assessment of SMS and Smartphone Interventions for OneTouch Reveal® Experiences

NCT02429024 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 138

Last updated 2016-09-14

No results posted yet for this study

Summary

Assessment of SMS and Smartphone Interventions for OneTouch Reveal® Experiences with patients with Type I and Type II diabetes.

Conditions

Interventions

DEVICE

OneTouch Reveal® Mobile APP

Diabetes management application for use on a mobile phone.

DEVICE

OneTouch Verio® Flex BGMS

Blood Glucose Monitoring System (BGMS)

Sponsors & Collaborators

  • Bio-Kinetic Europe, Ltd.

    collaborator INDUSTRY

  • LifeScan

    lead INDUSTRY

Principal Investigators

  • Mike Grady · LifeScan

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02429024 on ClinicalTrials.gov